Back
Cardiff Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
CRDF
Cardiff Oncology, Inc.
Last Price:
$3.18
Seasonality Move:
11.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing slight selling pressure.
Cardiff Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.7 | Buy |
| 20-day SMA: | 2.44 | Buy |
| 50-day SMA: | 2.29 | Buy |
| 200-day SMA: | 2.78 | Buy |
| 8-day EMA: | 2.79 | Buy |
| 20-day EMA: | 2.53 | Buy |
| 50-day EMA: | 2.32 | Buy |
| 200-day EMA: | 1.48 | Buy |
Cardiff Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 79.72 | Buy |
| Chaikin Money Flow: | -347210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.04 - 2.68) | Buy |
| Bollinger Bands (100): | (2.04 - 2.46) | Buy |
Cardiff Oncology, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiff Oncology, Inc. Stock
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 3.17 while CRDF 8-day simple moving average is 2.70, which is a Buy signal.
-
The stock price of CRDF is 3.17 while Cardiff Oncology, Inc. 20-day SMA is 2.44, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day simple moving average is 2.29 while CRDF share price is 3.17, making it a Buy technically.
-
CRDF stock price is 3.17 and Cardiff Oncology, Inc. 200-day simple moving average is 2.78, creating a Buy signal.
CRDF Technical Analysis vs Fundamental Analysis
Buy
67
Cardiff Oncology, Inc. (CRDF)
is a Buy
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a BuyThe current Cardiff Oncology, Inc. [CRDF] share price is $3.17. The Score for CRDF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Cardiff Oncology, Inc. Stock Info
Market Cap:
213.5M
Price in USD:
3.17
Share Volume:
1.2M
Cardiff Oncology, Inc. 52-Week Range
52-Week High:
4.99
52-Week Low:
1.90
Buy
67
Cardiff Oncology, Inc. (CRDF)
is a Buy
Cardiff Oncology, Inc. Share Price Forecast
-
What is the Cardiff Oncology, Inc. stock price today?The Cardiff Oncology, Inc. stock price is 3.17 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology, Inc. is not overvalued.
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 3.17 while CRDF 8-day exponential moving average is 2.79, which is a Buy signal.
-
The stock price of CRDF is 3.17 while Cardiff Oncology, Inc. 20-day EMA is 2.53, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day exponential moving average is 2.32 while CRDF share price is 3.17, making it a Buy technically.
-
CRDF stock price is 3.17 and Cardiff Oncology, Inc. 200-day simple moving average is 1.48, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology, Inc.
Is Cardiff Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.02 per share.
Technical Analysis of Cardiff Oncology, Inc.
Should I short Cardiff Oncology, Inc. stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Cardiff Oncology, Inc. is a Buy
-
Cardiff Oncology, Inc. Relative Strength Index (RSI) is 79.72, which suggest Cardiff Oncology, Inc. is overbought
-
The Bollinger Bands (25) for Cardiff Oncology, Inc. is (2.04 - 2.68), which suggest Cardiff Oncology, Inc. is a Buy
-
The Bollinger Bands (100) for Cardiff Oncology, Inc. is (2.04 - 2.46), which suggest Cardiff Oncology, Inc. is a Buy
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.